Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Minimally invasive surgery technology group Surgical Innovations narrowed first-half losses on rising sales.
Pre-tax losses for the six months through June amounted to £0.22 million, compared to year-on-year losses of £2.58 million. Revenue rose 63% to £4.22 million.
Adjusted earnings before interest, tax, depreciation and amortisation amounted to £0.21 million.
Net cash at 30 June was £2.66 million.
Surgical Innovations said revenues were recovering towards pre-pandemic levels in most markets, with is sales in the first two months of second half up 45% year-on-year and slightly up on 2019.
It added that it continued to trade profitably at the level of adjusted EBITDA, supported by a reduced cost base.